Sygnature Discovery Limited
Daniel Rial is a Senior Principal Scientist at Sygnature Discovery since October 2022, previously holding the position of Principal Scientist. Prior experience includes a role as a Scientific Researcher in the Department of Physiology, Anatomy & Genetics at the University of Oxford from April to November 2022, and serving as a Senior Research Scientist at the Medical Research Council's MRC Harwell from September 2019 to July 2022. Daniel Rial worked as a Researcher at Université libre de Bruxelles from April 2016 to September 2019 and was a Junior Post-doctoral researcher at Universidade de Coimbra from December 2012 to January 2015. The academic journey began with a PhD in Pharmacology from Universidade Federal de Santa Catarina, completed between 2009 and 2012, where Daniel Rial also conducted research as a PhD student from March 2009 to November 2012.
This person is not in any teams
This person is not in any offices
Sygnature Discovery Limited
2 followers
Sygnature Discovery are a leading drug discovery CRO with expertise across a range of therapeutic and biological target classes. An expert partner in disciplines including Medicinal and Computational Chemistry, In Vitro and In Vivo Pharmacology, DMPK, supported by informatics.